量化晨僵以评估类风湿关节炎疾病活动度与治疗效果
该初步研究开发了一种量化掌指关节被动阻力与被动活动范围的技术,在19例绝经后女性RA患者和9例健康对照中比较傍晚与次晨的差异,并在11例RA患者中评估糖皮质激素治疗前后的变化。结果显示RA患者晨间被动活动范围显著下降18%、僵硬显著增加20%,糖皮质激素显著改善上述指标,提示该技术对疾病状态和药物效应敏感。
要点
- RA患者晨间掌指关节被动活动范围较前日下午下降18%,僵硬增加20%。
- RA活动度与生物力学指标显著正相关。
- 糖皮质激素使被动活动范围增加16%、僵硬降低23%。
核心结论
- 该技术可量化掌指关节机械僵硬,对RA疾病状态和药物效应具有高敏感性。
研究设计与样本
- 初步研究,纳入19例绝经后女性RA患者和9例健康对照,于傍晚及次晨检查。
- 另对11例RA患者在糖皮质激素治疗前及约3小时后评估。
主要发现
- 健康对照傍晚与晨间仅轻微变化,RA患者晨间平均被动活动范围显著下降18%(s.d. 22)。
- RA患者晨间僵硬显著增加20%(s.d. 18)。
- RA活动度与生物力学指标显著正相关。
- 糖皮质激素使平均被动活动范围显著增加16%(s.d. 11),平均僵硬显著降低23%(s.d. 22)。
关键数值与推荐
- RA患者晨间被动活动范围较前日下午下降18%(s.d. 22),僵硬增加20%(s.d. 18)。
- 糖皮质激素治疗后被动活动范围增加16%(s.d. 11),僵硬降低23%(s.d. 22)。
临床怎么用
- 该无创、低风险、快速的生物力学评估可用于判断RA患者治疗疗效。
- 可能适用于其他非RA炎症性关节疾病。
局限性
- 原文未报告
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The clinical parameter of morning stiffness is widely used to assess the status of RA, but its accurate quantitative assessment in a clinical setting has not yet been successful. This lack of individual quantification limits both personalized medication and efficacy evaluation in the treatment of RA. METHODS: We developed a novel technology to assess passive resistance of the MCP III joint (stiffness) and its passive range of motion (PRoM). Within this pilot study, 19 female postmenopausal RA patients and 9 healthy controls were examined in the evening as well as the morning of the following day. To verify the specificity of the biomechanical quantification, 11 patients with RA were assessed both prior to and ∼3 h after glucocorticoid therapy. RESULTS: While the healthy controls showed only minor changes between afternoon and morning, in RA patients the mean PRoM decreased significantly by 18% (s.d. 22) and stiffness increased significantly by 20% (s.d. 18) in the morning compared with the previous afternoon. We found a significant positive correlation between RA activity and biomechanical measures. Glucocorticoids significantly increased the mean PRoM by 16% (s.d. 11) and reduced the mean stiffness by 23% (s.d. 22). CONCLUSION: This technology allowed mechanical stiffness to be quantified in MCP joints and demonstrated high sensitivity with respect to disease status as well as medication effect in RA patients. Such non-invasive, low-risk and rapid assessment of biomechanical joint stiffness opens a novel avenue for judging therapy efficacy in patients with RA and potentially also in other non-RA inflammatory joint diseases.
引用
- Boeth H, Biesen R, Hollnagel J, et al. Quantification of morning stiffness to assess disease activity and treatment effects in rheumatoid arthritis. Rheumatology (Oxford). 2021. PMID: 33822899. doi:10.1093/rheumatology/keab323
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。